IBDEI23O ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35245,1,4,0)
 ;;=4^N40.3
 ;;^UTILITY(U,$J,358.3,35245,2)
 ;;=^5015692
 ;;^UTILITY(U,$J,358.3,35246,0)
 ;;=N42.83^^163^1796^26
 ;;^UTILITY(U,$J,358.3,35246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35246,1,3,0)
 ;;=3^Prostate Cyst
 ;;^UTILITY(U,$J,358.3,35246,1,4,0)
 ;;=4^N42.83
 ;;^UTILITY(U,$J,358.3,35246,2)
 ;;=^322241
 ;;^UTILITY(U,$J,358.3,35247,0)
 ;;=N52.9^^163^1796^13
 ;;^UTILITY(U,$J,358.3,35247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35247,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,35247,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,35247,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,35248,0)
 ;;=R39.89^^163^1796^15
 ;;^UTILITY(U,$J,358.3,35248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35248,1,3,0)
 ;;=3^Genitourinary System Symptoms/Signs NEC
 ;;^UTILITY(U,$J,358.3,35248,1,4,0)
 ;;=4^R39.89
 ;;^UTILITY(U,$J,358.3,35248,2)
 ;;=^5019350
 ;;^UTILITY(U,$J,358.3,35249,0)
 ;;=R39.2^^163^1796^14
 ;;^UTILITY(U,$J,358.3,35249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35249,1,3,0)
 ;;=3^Extrarenal Uremia
 ;;^UTILITY(U,$J,358.3,35249,1,4,0)
 ;;=4^R39.2
 ;;^UTILITY(U,$J,358.3,35249,2)
 ;;=^5019348
 ;;^UTILITY(U,$J,358.3,35250,0)
 ;;=R30.1^^163^1796^29
 ;;^UTILITY(U,$J,358.3,35250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35250,1,3,0)
 ;;=3^Vesical Tenesmus
 ;;^UTILITY(U,$J,358.3,35250,1,4,0)
 ;;=4^R30.1
 ;;^UTILITY(U,$J,358.3,35250,2)
 ;;=^5019323
 ;;^UTILITY(U,$J,358.3,35251,0)
 ;;=Z85.46^^163^1796^16
 ;;^UTILITY(U,$J,358.3,35251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35251,1,3,0)
 ;;=3^Hx of Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,35251,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,35251,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,35252,0)
 ;;=N18.1^^163^1796^4
 ;;^UTILITY(U,$J,358.3,35252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35252,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,35252,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,35252,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,35253,0)
 ;;=N18.2^^163^1796^5
 ;;^UTILITY(U,$J,358.3,35253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35253,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,35253,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,35253,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,35254,0)
 ;;=N18.3^^163^1796^6
 ;;^UTILITY(U,$J,358.3,35254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35254,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,35254,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,35254,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,35255,0)
 ;;=N18.4^^163^1796^7
 ;;^UTILITY(U,$J,358.3,35255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35255,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,35255,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,35255,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,35256,0)
 ;;=N18.5^^163^1796^8
 ;;^UTILITY(U,$J,358.3,35256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35256,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,35256,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,35256,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,35257,0)
 ;;=N18.6^^163^1796^10
 ;;^UTILITY(U,$J,358.3,35257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35257,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,35257,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,35257,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,35258,0)
 ;;=N18.9^^163^1796^9
 ;;^UTILITY(U,$J,358.3,35258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35258,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,35258,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,35258,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,35259,0)
 ;;=N17.8^^163^1796^1
